netFormulary Berkshire West NHS NHS
Royal Berkshire Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Newbury and District CCG
North and West Reading CCG
South Reading CCG
Wokingham CCG
 
 Search
 Formulary Chapter 1: Gastro-intestinal system - Full Section
Notes:
This formulary is used by multiple organisations. There may be some instances where an item is on the formulary for one organisation but not the others. To help distinguish between each organisation, text will be colour coded, i.e. information relating to the Royal Berkshire NHS Foundation Trust will be in blue and Berkshire Healthcare NHS Foundation Trust will be in purple. Please ensure you read all information detailed under a drug.   
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
01.01 Dyspepsia and gastro-oesophageal reflux disease (1,3)
Dyspepsia (0,0)
Gastro-oesophageal reflux disease (0,0)
01.01.01 Antacids and simeticone (1,1)
Aluminium and magnesium containing antacids (2,5)
Aluminium-magnesium complexes (0,1)
Antacid preparations containing simeticone (1,2)
Simeticine alone (1,1)
Antacid preparations containing dimeticone or local anaesthetics (1,0)
01.01.02 Compound alginates and proprietary indigestion preparations (0,0)
Compound alginate preparations (4,5)
01.02 Antispasmodics and other drugs altering gut motility (1,0)
Antimuscarinics (2,4)
Other antispasmodics (8,2)
Motility stimulants (0,0)
01.03 Antisecretory drugs and mucosal protectants (0,0)
Helicobacter pylori infection (0,4)
NSAID-associated ulcers (0,0)
01.03.01 H2-receptor antagonists (2,7)
01.03.02 Selective antimuscarinics (0,0)
01.03.03 Chelates and complexes (1,1)
01.03.04 Prostaglandin analogues (1,0)
01.03.05 Proton pump inhibitors (PPIs) (7,6)
01.03.06 Other ulcer-healing drugs (0,0)
01.04 Acute diarrhoea (0,1)
01.04.01 Adsorbents and bulk-forming drugs (0,1)
01.04.02 Antimotility drugs (4,1)
01.04.03 Enkephalinase Inhibitors (0,0)
01.05 Chronic bowel disorders (0,0)
Irritable bowel syndrome (0,0)
Malabsorption syndromes (0,0)
Inflammatory bowel disease (0,0)
Antibiotic-associated colitis (0,0)
Diverticular disease (0,0)
Aminosalicylates (2,3)
Food allergy (0,0)
Cytokine inhibitors (0,0)
01.05.01 Aminosalicylates (5,3)
01.05.02 Corticosteroids (4,1)
01.05.03 Drugs affecting the immune response (8,0)
Cytokine inhibitors (4,0)
Vedolizumab (1,0)
01.05.04 Food allergy (0,1)
01.06 Laxatives (0,0)
01.06.01 Bulk-forming laxatives (4,4)
01.06.02 Stimulant laxatives (7,4)
Other Stimulant laxatives (0,0)
01.06.03 Faecal softeners (1,0)
01.06.04 Osmotic laxatives (5,2)
01.06.05 Bowel cleansing preparations (4,4)
01.06.06 Peripheral opiod-receptor antagonist (2,0)
01.06.07 5HT4 receptor agonists (2,0)
01.07 Local preparations for anal and rectal disorders (0,0)
01.07.01 Soothing haemorrhoidal preparations (3,0)
01.07.02 Compound haemorrhoidal preparations with corticosteroids (0,9)
01.07.03 Rectal sclerosants (2,0)
01.07.04 Management of anal fissures (1,0)
01.08 Stoma care (1,0)
01.09 Drugs affecting intestinal secretions (0,0)
01.09.01 Drugs affecting biliary composition and flow (2,5)
Other prepatations for biliary disorders (0,1)
01.09.02 Bile acid sequestrants (1,0)
01.09.03 Aprotinin (0,0)
01.09.04 Pancreatin (3,2)
netFormulary